Gene · 1282
Papers3,934
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,934
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug-Induced Gingival Overgrowth-Molecular Aspects of Drug Actions. | Int J Mol Sci | 2023 | 36982523 | PubTator, text mining | PubMed |
| Advantages of Understanding the Molecular Mechanisms of Angiogenesis in Various Physiological and Pathological Conditions. | Int J Mol Sci | 2023 | 36982487 | PubTator, text mining | PubMed |
| A Simplified and Effective Approach for the Isolation of Small Pluripotent Stem Cells Derived from Human Peripheral Blood. | Biomedicines | 2023 | 36979766 | PubTator, text mining | PubMed |
| MEX3B inhibits collagen production in eosinophilic nasal polyps by downregulating epithelial cell TGFBR3 mRNA stability. | JCI Insight | 2023 | 36976645 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 | 36973268 | PubTator, text mining | PubMed |
| Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction. | CNS Neurosci Ther | 2023 | 36971196 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals peritoneal environment and insights into fibrosis in CAPD patients. | iScience | 2023 | 36968085 | PubTator, text mining | PubMed |
| SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma. | BMC Urol | 2023 | 36959648 | PubTator, text mining | PubMed |
| Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets. | Mol Cell Proteomics | 2023 | 36958627 | PubTator, text mining | PubMed |
| Integration of Mendelian randomisation and systems biology models to identify novel blood-based biomarkers for stroke. | J Biomed Inform | 2023 | 36958462 | PubTator, text mining | PubMed |
| Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells. | Stem Cell Res Ther | 2023 | 36949528 | PubTator, text mining | PubMed |
| Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications. | J Hematol Oncol | 2023 | 36945046 | PubTator, text mining | PubMed |
| Exome-wide assessment of isolated biliary atresia: A report from the National Birth Defects Prevention Study using child-parent trios and a case-control design to identify novel rare variants. | Am J Med Genet A | 2023 | 36942736 | PubTator, text mining | PubMed |
| Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients. | PLoS One | 2023 | 36940196 | PubTator, text mining | PubMed |
| A multi-omic approach identifies an autism spectrum disorder (ASD) regulatory complex of functional epimutations in placentas from children born preterm. | Autism Res | 2023 | 36938998 | PubTator, text mining | PubMed |
| Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome. | Front Cell Dev Biol | 2023 | 36936689 | PubTator, text mining | PubMed |
| Analysis of transcriptome expression profiling data in oral leukoplakia and early and late‑stage oral squamous cell carcinoma. | Oncol Lett | 2023 | 36936021 | PubTator, text mining | PubMed |
| Aberrant expression of COL4A1 in age-related cataract and its effect on cell proliferation, apoptosis and gene expression changes. | Int J Ophthalmol | 2023 | 36935791 | PubTator, text mining | PubMed |
| Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice. | EBioMedicine | 2023 | 36933413 | PubTator, text mining | PubMed |
| Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer. | Cancer Immunol Immunother | 2023 | 36928373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1282/papers?page=36